Geneious Luma | End-to-End Antibody Discovery Platform for Biologics R&D
Geneious Luma is an integrated, AI-powered antibody discovery platform that unifies bioinformatics, in silico design, candidate ranking, and wet-lab execution into a seamless, customizable workflow—leveraging tools like Geneious Prime, Geneious Biologics, and AlphaFold—to accelerate biologics R&D by consolidating data, automating experiments, and enabling smarter, faster decision-making.
Geneious Luma brings together advanced bioinformatics, antibody discovery, and wet lab execution in one connected platform—accelerating design, screening, and production.
Legacy tools can’t keep up with the complexity of modern antibody discovery. Disconnected systems, rigid workflows, and data silos slow you down and drive up costs.
Geneious Luma is a comprehensive end-to-end antibody discovery solution purpose-built for biologics R&D. From in silico design and AI-powered candidate ranking to wet-lab execution and automated registration, Geneious Luma unifies the entire discovery process in a single, intelligent workspace.
Powered by industry standard tools including Geneious Prime and Geneious Biologics—and seamlessly integrated with tools like GraphPad Prism, Protein Metrics, and BioGlyph—Geneious Luma connects every step of R&D into one continuous, traceable workflow.
Design Smarter, Discover Faster—With Geneious Luma
Leverage the power of Geneious Prime and Geneious Biologics to annotate sequences, design constructs, and accelerate early discovery. Get deeper scientific context at every step with intuitive tools purpose-built for biologics research.
Connect Molecules, Assays, and Endpoints with One View
Consolidate your data—from molecule designs to characterization and assay results—into customizable dashboards that surface the most promising candidates. Eliminate silos and make confident, informed decisions faster.
Streamline Wet-Lab Workflows with AI-Powered Precision
Use customizable workflows to guide and automate your experimental execution, from cloning to purification. Built-in AI surfaces key insights and streamlines every phase of development.
Protein Design & Engineering
Proteins are complex and are designed by dedicated teams. They use tools like AlphaFold to predict structures and modify properties.
Cloning Design & Execution
Molecular designs are broken into parts. Scientists use Geneious to design the cellular components for making the parts, which are then made in the lab.
Express, Purify & Structural Characterization
The cellular components from the prior step are inserted into living cells that make the proteins. These must be purified and analyzed for structural detail.
Functional Assay Development & Execution
Pure proteins are tested for functional properties. These results, intersected with molecular structure, are used for subsequent decisions.
Visual Decision Support at a Glance
Create intuitive decision support dashboards that display all relevant data in a clear, visual format to easily interpret and analyze complex information.
Customer Impact
Beyond JSON: Centralizing, Modeling, and Aggregating Instrument Data to Enable Deeper Analysis
Learn how the adoption of a multimodal Scientific Intelligence Platform transforms the way scientists work, highlighted by a real-world case study of a leading life sciences company using the technology to facilitate multispecific antibody discovery and protein engineering.
Ready to unify your biologics discovery workflows?
Request a personalized demo to see how Geneious Luma connects design, registration, and execution in one intelligent platform.
Related
The Data Lifecycle: From Instrument Integration to Advanced Analysis
The article discusses how Dotmatics Luma™, a comprehensive scientific data platform, addresses the challenges faced by R&D teams in managing and integrating diverse, multimodal scientific data from instruments and various sources to streamline the entire data lifecycle—from ingestion and processing to advanced analysis—thereby enabling faster, AI-ready insights that accelerate innovation and research outcomes.
Why Your ELN Data Is Stuck — and How to Fix It
The article explains that traditional ELN data often remains unusable because it is stored as static attachments, but Luma solves this by directly connecting instrument data to ELNs and presenting it as live, interactive dashboards that harmonize multi-vendor data in real time, enabling filtering, calculations, and full audit trails within the experiment notebook.
Dotmatics aims to speed drug development and break data silos with Geneious Luma
Dotmatics has launched Geneious Luma, an AI-driven platform featured in VentureBeat, designed to accelerate drug discovery by streamlining workflows, integrating data to eliminate silos, and enabling biopharma researchers to uncover insights faster for improved therapeutic development.
Luma Antibody & Protein Engineering Solution for End-to-End Antibody Discovery
Dotmatics has launched the Luma Antibody & Protein Engineering Solution, the first in its Luma Multimodal R&D Solutions series, which integrates the Dotmatics Luma Scientific Intelligence Platform with key tools like Geneious, GraphPad Prism, and others to streamline and unify antibody discovery and development—particularly for monoclonal and multispecific antibodies—while supporting a broad range of therapeutic modalities including CAR-T, siRNA, ADCs, CRISPR, and vaccines within a collaborative, multimodal research environment.
From Data Silos to AI-Ready Science: The Vision Behind Dotmatics Luma
Dotmatics Luma is a new, AI-driven, multimodal scientific platform designed to overcome data silos and fragmented R&D systems by uniting diverse scientific software and streamlining workflows across biologics, small molecule, and materials discovery, enabling smarter, faster, and more collaborative drug discovery and therapeutics development at the enterprise level.
Dotmatics Launches BioGlyph Luma to Accelerate the Future of Protein Design & Engineering
Dotmatics has launched BioGlyph Luma, a next-generation protein design and engineering solution integrated into its Luma Scientific Intelligence Platform, which addresses the Design phase of the protein therapeutics research cycle by enabling real-time traceability, scalable registration, and seamless integration with existing scientific tools to accelerate multimodal biologic R&D workflows with precision and data-driven automation.